title: Single intravitreal aflibercept injection for unilateral acute nonarteritic ischemic optic neuropathy.
abstract: Acute nonarteritic ischemic optic neuropathy (ANAION) is the most common optic neuropathy in the elderly population without a well-established treatment. A 67-year-old man with a sudden painless visual loss in his left eye of one-day duration was diagnosed to have left ANAION. Next day, 2 mg aflibercept injection was injected intravitreally in OS. Visual acuity improved to 7/10 from 1/10 a week after the injection. Mean retinal nerve fiber layer thickness (RNFLT) was reduced to 159,7 μm from 182,4 μm at the first week. Visual fields improved dramatically during the follow-up of three months. The aim of this study is to present a case having ANAION treated with a single intravitreal aflibercept injection and discuss the place of intravitreal anti-VEGF injections in the treatment of armamentarium of ANAION.
authors: Department of Ophthalmology, Dokuz Eylül University, 35320 İzmir, Turkey.
authors: Ziya
authors: Z
authors: Ayhan
authors: Department of Ophthalmology, Dokuz Eylül University, 35320 İzmir, Turkey.
authors: Gamze
authors: G
authors: Kocaoğlu
authors: Department of Ophthalmology, Dokuz Eylül University, 35320 İzmir, Turkey.
authors: Aylin
authors: 0000-0002-0391-5420
authors: A
authors: Yaman
authors: Department of Ophthalmology, Dokuz Eylül University, 35320 İzmir, Turkey.
authors: Meltem Söylev
authors: MS
authors: Bajin
authors: Department of Ophthalmology, Dokuz Eylül University, 35320 İzmir, Turkey.
authors: A Osman
authors: AO
authors: Saatci
references: Br J Ophthalmol. 1974 Dec;58(12):981-9
references: 4376417
references: Arch Ophthalmol. 2008 Jun;126(6):812-5
references: 18541844
references: Clin Exp Optom. 2008 Nov;91(6):561-4
references: 18976422
references: Klin Monbl Augenheilkd. 1992 May;200(5):349-53
references: 1614099
references: Indian J Ophthalmol. 2010 Jul-Aug;58(4):349-50
references: 20534939
references: Open Ophthalmol J. 2013 Sep 30;7:58-62
references: 24133556
references: J Neuroophthalmol. 2007 Sep;27(3):164-8
references: 17895814
references: Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):1029-46
references: 18404273
references: J Neuroophthalmol. 2007 Sep;27(3):238-40
references: 17895825
references: Clin Exp Optom. 2011 Jul;94(4):367-70
references: 21255078
references: J Neuroophthalmol. 2012 Jun;32(2):193
references: 22549561
references: Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3671-6
references: 18660428
references: Br J Ophthalmol. 1974 Dec;58(12):955-63
references: 4376415
references: Clin Exp Optom. 2009 Jul;92(4):397
references: 19570152
references: Jpn J Ophthalmol. 2010 May;54(3):252-4
references: 20577866
references: JAMA. 1995 Feb 22;273(8):625-32
references: 7844872
references: Eye (Lond). 2014 Dec;28(12):1494-501
references: 25257770
references: Eye (Lond). 2013 Apr;27(4):538-44
references: 23370417
references: Ophthalmology. 2009 Nov;116(11):2264.e1-3
references: 19883862
references: J Ocul Pharmacol Ther. 2010 Oct;26(5):523-7
references: 20874667